Table 1.
Clinical and laboratory characteristics of the RA and OA patients
| Diagnosis | Sex | Age (years) | ACPA, (U/ml) | RF (IU/ml) | ESR (mm/h) | CRP (mg/dl) | Disease duration (years) | DAS28 |
|---|---|---|---|---|---|---|---|---|
| RA | Female | 61 | >200 | 86.3 | 64 | 25.1 | 3 | 4.28 |
| RA | Female | 79 | >200 | 397 | 109 | 42.7 | 4 | 4.93 |
| RA | Female | 73 | >200 | 40.6 | 44 | 37.5 | 2 | 3.84 |
| RA | Male | 69 | >200 | 24.5 | 29 | 27.3 | 3 | 3.43 |
| RA | Male | 63 | >200 | 142 | 44 | 77.8 | 5 | 3.72 |
| RA | Male | 70 | >200 | 102 | 82 | 31.4 | 2 | 4.16 |
| OA | Female | 68 | <0.5 | <20 | 8 | 8.9 | 2 | _ |
| OA | Female | 53 | <0.5 | <20 | 7 | 7.8 | 3 | _ |
| OA | Female | 63 | <0.5 | <20 | 5 | 2.5 | 2 | _ |
| OA | Male | 69 | <0.5 | <20 | 3 | 0.6 | 5 | _ |
| OA | Male | 54 | <0.5 | <20 | 7 | 4.3 | 4 | _ |
| OA | Male | 58 | <0.5 | <20 | 14 | 9.9 | 3 | _ |
ACPA anticitrullinated protein antibody, RF rheumatoid factor, ESR erythrocyte sedimentation rate, CRP C-reactive protein, DAS28 disease activity score at 28 joints